Contraceptive Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Intrauterine Contraceptive Devices Market Analysis and is Segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Device (IUD), and Other Types), Gender (Male and Female) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The value is provided in terms of (USD million) for the above segments.

Contraceptive Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Contraceptive Devices Market Size

contraceptive devices market
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 13.44 Billion
Market Size (2030) USD 17.69 Billion
CAGR (2025 - 2030) 5.65 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Contraceptive Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Contraceptive Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Contraceptive Devices Market Analysis

The Contraceptive Devices Market size is estimated at USD 13.44 billion in 2025, and is expected to reach USD 17.69 billion by 2030, at a CAGR of 5.65% during the forecast period (2025-2030).

The COVID-19 pandemic has impacted the growth of the studied market. Initially, the global COVID-19 outbreak and the lockdown scenario in the country have imposed some challenges on the market, as hospitals and clinics were forced to suspend services to prevent the spread of the SARS-CoV-2 virus. The restrictions imposed by the government have significantly impacted the growth of the studied market during the initial period of the pandemic. For instance, according to an article published in March 2022, titled 'Effect of the COVID-19 pandemic on contraceptive prescribing in general practice: a retrospective analysis of English prescribing data between 2019 and 2020', it has been observed that the use of long-acting contraceptives decreased, with implants by 76%, intrauterine systems by 79% and intrauterine devices by 76%. However, with the released COVID-19 restrictions and resumed services, the studied market is expected to grow over the forecast period.

Certain factors that are propelling the market growth are increasing awareness about sexually transmitted diseases, the rising rate of unintended pregnancies, and growing government initiatives.

Unwanted pregnancies are becoming more prevalent globally and are a major cause for concern. For instance, according to the United Nations Population Fund, in March 2022, unintended pregnancies accounted for about half of all pregnancies worldwide, with 121 million occurring each year. As per the same source, over 60% of unplanned pregnancies end in abortion, with an estimated 45% of all abortions being unsafe, resulting in 5%-13% of all maternal fatalities, putting the world's capacity to meet the "Sustainable Development Goals" at risk. Thus, the high rate of unintended pregnancies and unsafe abortions are expected to increase the demand for contraceptive devices, which in turn is anticipated to propel market growth.

In addition, the rising prevalence of sexually transmitted diseases among the population is expected to increase market growth. For instance, according to the report published by the Centers for Disease Control and Prevention in April 2022, it reported that around 133,945 cases of all stages of syphilis were noted,which includes 41,655 cases of primary and secondary syphilis which is considered the most infectious stages of the disease. It also reported an increase of 6.8% in Syphilis during the period 2019 to 2020. The same report also indicated that around 2,148 cases of congenital syphilis were reported in 2020, which includes 149 congenital syphilis-related stillbirths and infant deaths. Additionally, according to the data published by the World Health Organization, in November 2021, it has been observed that around 374 million new infections with one of four sexually transmitted diseases - chlamydia (129 million), gonorrhea (82 million), syphilis (7.1 million) and trichomoniasis (156 million) were recorded in 2020. Thus, the rising burden of sexually transmitted diseases is expected to increase the demand for contraception to avoid getting diseases, thereby propelling market growth.

However, the side effects associated with the use of contraceptive devices are likely to impede the market growth over the forecast period.

Contraceptive Devices Industry Overview

The contraceptive devices market is fragmented with the presence of key market players. The majority of the contraceptive devices are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market studied. Moreover, Asia-Pacific has been witnessing the emergence of some small players due to the rise of awareness. This has also helped the studied market to grow.Some of the key players in the market are AbbVie (Allergan PLC), Bayer AG, Cooper Surgical Inc., Reckitt Benckiser, Pregna International Limited and Teva Pharmaceutical Industries Ltd.

Contraceptive Devices Market Leaders

  1. Pregna International Limited

  2. Cooper Surgical Inc.

  3. Reckitt Benckiser Group PLC

  4. Bayer AG

  5. AbbVie (Allergan PLC)

  6. *Disclaimer: Major Players sorted in no particular order
Contraceptive Devices Market - CL.png
Need More Details on Market Players and Competiters?
Download PDF

Contraceptive Devices Market News

In April 2022, ProMed Pharma began preclinical evaluation of a novel fully resorbable contraceptive implant after getting the funds from Bill and Melinda Gates Foundation.

In February 2022, Mithra and Searchlight Pharma launched Myring, Mithra's vaginal contraceptive ring, under the brand name Haloette in Canada.

Contraceptive Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Awareness about Sexually Transmitted Diseases (STDs)
    • 4.2.2 Rising Rate of Unintended Pregnancies
    • 4.2.3 Rise in Government Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated with the Use of Contraceptive Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Condoms
    • 5.1.2 Diaphragms
    • 5.1.3 Cervical Caps
    • 5.1.4 Sponges
    • 5.1.5 Vaginal Rings
    • 5.1.6 Intra Uterine Device (IUD)
    • 5.1.7 Other Types
  • 5.2 By Gender
    • 5.2.1 Male
    • 5.2.2 Female
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AbbVie (Allergan PLC)
    • 6.1.2 Bayer AG
    • 6.1.3 Cooper Surgical Inc.
    • 6.1.4 Viatris, Inc. (Mylan Laboratories)
    • 6.1.5 Pfizer Inc.
    • 6.1.6 Teva Pharmaceutical Industries Ltd
    • 6.1.7 DKT International
    • 6.1.8 Pregna International Limited
    • 6.1.9 Reckitt Benckiser
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Contraceptive Devices Industry Segmentation

As per the scope of the report, contraceptive devices have been barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide. The Contraceptive Devices Market is segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Device (IUD), and Other Types), Gender (Male and Female), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Type Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Device (IUD)
Other Types
By Gender Male
Female
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Contraceptive Devices Market Research FAQs

How big is the Contraceptive Devices Market?

The Contraceptive Devices Market size is expected to reach USD 13.44 billion in 2025 and grow at a CAGR of 5.65% to reach USD 17.69 billion by 2030.

What is the current Contraceptive Devices Market size?

In 2025, the Contraceptive Devices Market size is expected to reach USD 13.44 billion.

Who are the key players in Contraceptive Devices Market?

Pregna International Limited, Cooper Surgical Inc., Reckitt Benckiser Group PLC, Bayer AG and AbbVie (Allergan PLC) are the major companies operating in the Contraceptive Devices Market.

Which is the fastest growing region in Contraceptive Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Contraceptive Devices Market?

In 2025, the North America accounts for the largest market share in Contraceptive Devices Market.

What years does this Contraceptive Devices Market cover, and what was the market size in 2024?

In 2024, the Contraceptive Devices Market size was estimated at USD 12.68 billion. The report covers the Contraceptive Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Contraceptive Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Contraceptive Devices Industry Report

Statistics for the 2025 Contraceptive Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Contraceptive Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.